- By Native News Online Staff
A study released on Friday by the Centers for Disease Control and Prevention (CDC), show booster shots of the of the Pfizer-BioNTech and Moderna vaccines lose effectiveness after four months, but still provide significant protection that keeps low hospitalization rates during the Omicron surge.
The study’s research indicates booster shots remain very effective against moderate and severe COVID-19 for about two months after the third shot, but their effectiveness wanes after four months, which suggests the need for additional boosters.
Researchers found during the Omicron variant, vaccine effectiveness against outpatient visits was 87 percent in people who had received the booster two months earlier but declined to 66 percent after four months. Hospitalization rates for those who received the booster fell from 91 percent at two months to 78 percent after four months.
According to a press release from the CDC on boosters, boosters are safe and effective, and CDC continues to recommend everyone 5 and older remain up to date with recommended COVID-19 vaccinations, to ensure optimal protection against hospitalizations and severe outcomes. For most people, that means getting a booster dose 5 months after receiving an mRNA vaccine or 2 months after receiving Johnson and Johnson’s Janssen vaccine. CDC is continuing to closely monitor the effectiveness of COVID-19 vaccines to help inform public health efforts.
The Indian Health Service (IHS) is continues to distribute all three COVID-19 vaccines currently authorized or approved in the U.S, including Pfizer-BioNTech, Moderna, and Janssen/Johnson & Johnson.
Every home in the U.S. is eligible to order four free at-home COVID-19 tests. The tests are completely free. Orders will usually ship in 7-12 days. Order your tests now so you have them when you need them. If you need a COVID-19 test now, please see other testing resources for free testing locations in your area. CLICK to order.
More Stories Like This‘We are in dark times’ | Reeling from Four Overdose Deaths in Four Days, Lummi Nation Calls for Urgent Action
IHS Awards $1.5 Million to Address Alzheimer's Disease
Statement from IHS Director Roselyn Tso on the Availability of Updated COVID-19 Vaccines
Promote Hope for the Future: Addressing Suicide in Indigenous Youth
Ovarian Cancer Affects 20,000 Women a Year. Here's What You Need to Know.